These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29024245)

  • 1. hace1 Influences zebrafish cardiac development via ROS-dependent mechanisms.
    Razaghi B; Steele SL; Prykhozhij SV; Stoyek MR; Hill JA; Cooper MD; McDonald L; Lin W; Daugaard M; Crapoulet N; Chacko S; Lewis SM; Scott IC; Sorensen PHB; Berman JN
    Dev Dyn; 2018 Feb; 247(2):289-303. PubMed ID: 29024245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes.
    Daugaard M; Nitsch R; Razaghi B; McDonald L; Jarrar A; Torrino S; Castillo-Lluva S; Rotblat B; Li L; Malliri A; Lemichez E; Mettouchi A; Berman JN; Penninger JM; Sorensen PH
    Nat Commun; 2013; 4():2180. PubMed ID: 23864022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction.
    Cetinbas N; Daugaard M; Mullen AR; Hajee S; Rotblat B; Lopez A; Li A; DeBerardinis RJ; Sorensen PH
    Oncogene; 2015 Jul; 34(30):4005-10. PubMed ID: 25284589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HACE1 is a potential tumor suppressor in osteosarcoma.
    El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH
    Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation.
    Castillo-Lluva S; Tan CT; Daugaard M; Sorensen PH; Malliri A
    Oncogene; 2013 Mar; 32(13):1735-42. PubMed ID: 22614015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1.
    Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E
    Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson's disease models.
    Zang CX; Wang L; Yang HY; Shang JM; Liu H; Zhang ZH; Ju C; Yuan FY; Li FY; Bao XQ; Zhang D
    Acta Pharmacol Sin; 2022 Feb; 43(2):285-294. PubMed ID: 34593974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
    Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
    Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress.
    Zhang L; Chen X; Sharma P; Moon M; Sheftel AD; Dawood F; Nghiem MP; Wu J; Li RK; Gramolini AO; Sorensen PH; Penninger JM; Brumell JH; Liu PP
    Nat Commun; 2014 Mar; 5():3430. PubMed ID: 24614889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression.
    Goka ET; Lippman ME
    Oncogene; 2015 Oct; 34(42):5395-405. PubMed ID: 25659579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression.
    Li JC; Chang X; Chen Y; Li XZ; Zhang XL; Yang SM; Hu CJ; Zhang H
    Curr Drug Targets; 2019; 20(10):1018-1028. PubMed ID: 30827236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E3 ubiquitin ligase Hace1 is required for early embryonic development in Xenopus laevis.
    Iimura A; Yamazaki F; Suzuki T; Endo T; Nishida E; Kusakabe M
    BMC Dev Biol; 2016 Sep; 16(1):31. PubMed ID: 27653971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation.
    Andrio E; Lotte R; Hamaoui D; Cherfils J; Doye A; Daugaard M; Sorensen PH; Bost F; Ruimy R; Mettouchi A; Lemichez E
    Sci Rep; 2017 Mar; 7():44779. PubMed ID: 28317937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression dynamics of NADPH oxidases during early zebrafish development.
    Weaver CJ; Leung YF; Suter DM
    J Comp Neurol; 2016 Jul; 524(10):2130-41. PubMed ID: 26662995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes.
    Turgu B; El-Naggar A; Kogler M; Tortola L; Zhang HF; Hassan M; Lizardo MM; Kung SH; Lam W; Penninger JM; Sorensen PH
    EMBO Rep; 2023 Dec; 24(12):e56815. PubMed ID: 37846480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases.
    Kogler M; Tortola L; Negri GL; Leopoldi A; El-Naggar AM; Mereiter S; Gomez-Diaz C; Nitsch R; Tortora D; Kavirayani AM; Gapp BV; Rao S; Uribesalgo I; Hoffmann D; Cikes D; Novatchkova M; Williams DA; Trent JM; Ikeda F; Daugaard M; Hagelkruys A; Sorensen PH; Penninger JM
    Cancer Res; 2020 Jul; 80(14):3009-3022. PubMed ID: 32366477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
    Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
    Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis for the Enzymatic Activity of the HACE1 HECT-Type E3 Ligase Through N-Terminal Helix Dimerization.
    Singh S; Machida S; Tulsian NK; Choong YK; Ng J; Shankar S; Liu Y; Chandiramani KV; Shi J; Sivaraman J
    Adv Sci (Weinh); 2023 Sep; 10(27):e2207672. PubMed ID: 37537642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance.
    Gao ZF; Wu YN; Bai ZT; Zhang L; Zhou Q; Li X
    Oncol Rep; 2016 Dec; 36(6):3427-3435. PubMed ID: 27805249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.
    Bouzelfen A; Alcantara M; Kora H; Picquenot JM; Bertrand P; Cornic M; Mareschal S; Bohers E; Maingonnat C; Ruminy P; Adriouch S; Boyer O; Dubois S; Bastard C; Tilly H; Latouche JB; Jardin F
    Leuk Res; 2016 Jun; 45():90-100. PubMed ID: 27107267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.